Cognitive behavior therapy boosts outcomes in depressed diabetes patients

11/1/2013 | DailyRx.com

Data on patients with uncontrolled type 2 diabetes and depression revealed that those who underwent cognitive behavioral therapy for adherence and depression attained better HbA1C levels and exhibited greater adherence to oral medication and self-monitoring of blood glucose at four months compared with those in the Enhanced Treatment as Usual arm. The findings were published in Diabetes Care.

View Full Article in:

DailyRx.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
MGR POST MARKET STUDIES - 14000001LK
Abbott
Santa Ana, CA
Regulatory Analyst
Delta Dental
Alpharetta, GA
Program Coordinator/Lecturer for the Regulatory Science program
Johns Hopkins University
Washington, DC
Eastern Zone Sales Director
Regenesis Biomedical
Multiple Locations, SL_Multiple Locations
Senior Financial Analyst - Growing Manager Care Health Org
Fallon Community Health Plan
Worcester, MA